These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2485192)

  • 21. Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis.
    Tjandra K; Sharkey KA; Swain MG
    Hepatology; 2000 Feb; 31(2):280-90. PubMed ID: 10655247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sclerosing cholangitis caused by sterilization of a hydatid cyst of the liver with a hypertonic saline solution].
    Prat F; Ouzan D; Trépo C
    Gastroenterol Clin Biol; 1988 Nov; 12(11):867-9. PubMed ID: 3220238
    [No Abstract]   [Full Text] [Related]  

  • 23. Small bile duct abnormalities and chronic intrahepatic cholestasis in Behçet's syndrome.
    Hisaoka M; Haratake J; Nakamura T
    Hepatogastroenterology; 1994 Jun; 41(3):267-70. PubMed ID: 7959551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is cetrimide-chlorhexidine risky for secondary sclerosing cholangitis?
    Aydin C; Kayaalp C; Nessar G; Zengin N; Balkan M; Unal B; Ozgurtas T
    Adv Clin Exp Med; 2014; 23(3):395-8. PubMed ID: 24979510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathology of cholestasis.
    Desmet VJ
    Verh Dtsch Ges Pathol; 1995; 79():233-40. PubMed ID: 8600686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of phalloidin on cholestasis, hemodynamics, and microcirculation in isolated perfused rat liver.
    Barriault C; Petit JL; Gascon-Barré M; Huet PM; Yousef IM; Tuchweber B
    Hepatology; 1996 Feb; 23(2):294-302. PubMed ID: 8591855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver involvement and its course in experimental colitis in rats.
    Wojczys R
    Hepatogastroenterology; 1997; 44(16):1193-5. PubMed ID: 9261623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis.
    Nakazawa T; Ohara H; Sano H; Ando T; Aoki S; Kobayashi S; Okamoto T; Nomura T; Joh T; Itoh M
    Pancreas; 2005 Jan; 30(1):20-5. PubMed ID: 15632695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.
    Gelbmann CM; Rümmele P; Wimmer M; Hofstädter F; Göhlmann B; Endlicher E; Kullmann F; Langgartner J; Schölmerich J
    Am J Gastroenterol; 2007 Jun; 102(6):1221-9. PubMed ID: 17531010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis.
    Nakazawa T; Ohara H; Yamada T; Ando H; Sano H; Kajino S; Hashimoto T; Nakamura S; Ando T; Nomura T; Joh T; Itoh M
    Hepatogastroenterology; 2001; 48(39):625-30. PubMed ID: 11462890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
    Sánchez-Muñoz D; Castellano-Megías VM; Romero-Gómez M
    Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sclerosing cholangitis following the treatment of echinococcosis of the liver.
    Khodadadi DJ; Kurgan A; Schmidt B
    Int Surg; 1981; 66(4):361-2. PubMed ID: 7345052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'.
    Uehara T; Hamano H; Kawa S; Sano K; Honda T; Ota H
    Pathol Int; 2005 Jul; 55(7):405-11. PubMed ID: 15982215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
    Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.
    Linder S; Söderlund C
    Hepatogastroenterology; 2001; 48(38):387-92. PubMed ID: 11379315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sclerosing cholangitis after burn injury].
    Schmitt M; Kölbel CB; Müller MK; Verbeke CS; Singer MV
    Z Gastroenterol; 1997 Oct; 35(10):929-34. PubMed ID: 9432814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis.
    Henkel C; Roderfeld M; Weiskirchen R; Berres ML; Hillebrandt S; Lammert F; Meyer HE; Stühler K; Graf J; Roeb E
    Proteomics; 2006 Dec; 6(24):6538-48. PubMed ID: 17109383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation in an adult with sclerosing cholangitis due to Langerhans cell histiocytosis.
    Griffiths W; Davies S; Gibbs P; Thillainayagam A; Alexander G
    J Hepatol; 2006 Apr; 44(4):829-31. PubMed ID: 16483684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe eosinophilic cholangitis with parenchymal destruction of the left hepatic lobe due to hydatid disease.
    Raptou G; Pliakos I; Hytiroglou P; Papavramidis S; Karkavelas G
    Pathol Int; 2009 Jun; 59(6):395-8. PubMed ID: 19490470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sclerosing cholangitis-induced biliary cyst formation: complication of hepatic artery infusion chemotherapy].
    Miyamoto S; Umekita N; Maeshiro T; Awane Y
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1684-6. PubMed ID: 7574792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.